We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Top Buys

Rank Stock Value
1
CEG icon
Constellation Energy
CEG
+$6.48M
2
AMK
AssetMark Financial Holdings, Inc.
AMK
+$6.21M
3
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$6.05M
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$5.93M
5
FTRE icon
Fortrea Holdings
FTRE
+$5.34M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$16.5M
2
NVDA icon
NVIDIA
NVDA
+$13.1M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$9.16M
4
VIPS icon
Vipshop
VIPS
+$8.72M
5
CSTR
CapStar Financial Holdings, Inc
CSTR
+$8.17M

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GANX icon
1151
Gain Therapeutics
GANX
$77.6M
$45.9K ﹤0.01%
35,820
– –
DCGO icon
1152
DocGo
DCGO
$62.6M
$45.7K ﹤0.01%
+14,800
New +$48.7K
VIGL
1153
DELISTED
Vigil Neuroscience
VIGL
$43.5K ﹤0.01%
10,867
-9,510
-47% -$32.5K
CRBU icon
1154
Caribou Biosciences
CRBU
$164M
$43.3K ﹤0.01%
26,410
+6,800
+35% +$21.7K
CIFR icon
1155
Cipher Digital
CIFR
$7.13B
$42.7K ﹤0.01%
+10,286
New +$42.6K
PRLD icon
1156
Prelude Therapeutics
PRLD
$390M
$42.2K ﹤0.01%
11,074
-2,772
-20% -$11.3K
SGMT icon
1157
Sagimet Biosciences
SGMT
$559M
$42.1K ﹤0.01%
12,300
+2,100
+21% +$9.63K
CMLS
1158
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$41.5K ﹤0.01%
20,352
-1,061
-5% -$2.75K
AEVA
1159
Aeva Technologies
AEVA
$1.86B
$40.8K ﹤0.01%
+16,200
New +$52.8K
VOXX
1160
DELISTED
VOXX International Corporation Class A
VOXX
$40.1K ﹤0.01%
+12,700
New +$67.6K
EXFY icon
1161
Expensify
EXFY
$245M
$39.9K ﹤0.01%
26,800
-19,500
-42% -$30.7K
TLRY icon
1162
Tilray
TLRY
$622M
$39.7K ﹤0.01%
2,390
+1,275
+114% +$24.5K
SVM
1163
Silvercorp Metals
SVM
$2.53B
$36.2K ﹤0.01%
10,779
-3,784
-26% -$13.7K
RMNI icon
1164
Rimini Street
RMNI
$471M
$36K ﹤0.01%
11,712
-4,800
-29% -$13.2K
GAN
1165
DELISTED
GAN Ltd
GAN
$35.3K ﹤0.01%
23,918
– –
RAPT
1166
DELISTED
RAPT Therapeutics
RAPT
$33.2K ﹤0.01%
+1,363
New +$63K
NFGC
1167
New Found Gold
NFGC
$641M
$28.4K ﹤0.01%
+10,024
New +$35.3K
MATH icon
1168
Metalpha Technology Holding
MATH
$42.1M
$28.4K ﹤0.01%
+20,547
New +$30.1K
VTYX
1169
DELISTED
Ventyx Biosciences
VTYX
$28K ﹤0.01%
12,100
-25,300
-68% -$105K
PACB icon
1170
Pacific Biosciences
PACB
$370M
$26.1K ﹤0.01%
19,086
+1,236
+7% +$2.5K
RGLS
1171
DELISTED
Regulus Therapeutics
RGLS
$25.2K ﹤0.01%
14,100
-118,370
-89% -$275K
ALLK
1172
DELISTED
Allakos
ALLK
$25K ﹤0.01%
25,000
– –
IRD
1173
Opus Genetics
IRD
$302M
$21.2K ﹤0.01%
13,852
-6,766
-33% -$11.7K
SLDP icon
1174
Solid Power
SLDP
$532M
$19.9K ﹤0.01%
+12,060
New +$20.8K
RLYB icon
1175
Rallybio
RLYB
$85.8M
$18.5K ﹤0.01%
+1,725
New +$23.4K
45 46
47
48 49

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.